The cancer stem cell (CSC) model is describing tumors as a hierarchical organized system and CSCs are suggested to be responsible for cancer recurrence after therapy. The identification of specific markers of CSCs is therefore of paramount importance. Here, we show that high levels of lipid droplets (LDs) are a distinctive mark of CSCs in colorectal (CR) cancer. This increased lipid content was clearly revealed by label-free Raman spectroscopy and it directly correlates with well-accepted CR-CSC markers as CD133 and Wnt pathway activity. By xenotransplantation experiments, we have finally demonstrated that CR-CSCs overexpressing LDs retain most tumorigenic potential. A relevant conceptual advance in this work is the demonstration that a cel...
Background Lipid-rich tumours have been associated with increased cancer metastasis and aggressive c...
Cancer stem cells (CSCs) are rare types of cells responsible for tumor development, relapse, and met...
Colon cancer constitutes 33% of all cancer cases in humans and the majority of patients with metasta...
The Cancer Stem Cell (CSC) model is describing tumors as a hierarchical organized system and CSCs a...
The cancer stem cell (CSC) model is describing tumors as a hierarchical organized system and CSCs ar...
Abstract Background Cancer stem cells (CSCs) or tumor-initiating cells (TICs) represent a small popu...
Lack of sensitive single-cell analysis tools has limited the characterization of metabolic activity ...
For decades, lipid droplets have been considered as the main cellular organelles involved in the fat...
Among all neoplasms, melanoma is characterized by a very high percentage of cancer stem cells (CSCs)...
Cancer cells have been known to have reprogrammed metabolism since 1920s, when Otto Warburg observed...
Lipid Droplets (LDs) are emerging as crucial players in colon cancer development and maintenance. Th...
International audienceFor many years, scientists have been looking for specific biomarkers associate...
Label-free live single-cell Raman spectroscopy was used to obtain a chemical fingerprint of colorect...
The development of a colorectal adenoma (CA) into carcinoma (CRC) is a long and stealthy process. Th...
Colorectal cancer (CRC) is the fourth leading cause of cancer death in the world. Despite the screen...
Background Lipid-rich tumours have been associated with increased cancer metastasis and aggressive c...
Cancer stem cells (CSCs) are rare types of cells responsible for tumor development, relapse, and met...
Colon cancer constitutes 33% of all cancer cases in humans and the majority of patients with metasta...
The Cancer Stem Cell (CSC) model is describing tumors as a hierarchical organized system and CSCs a...
The cancer stem cell (CSC) model is describing tumors as a hierarchical organized system and CSCs ar...
Abstract Background Cancer stem cells (CSCs) or tumor-initiating cells (TICs) represent a small popu...
Lack of sensitive single-cell analysis tools has limited the characterization of metabolic activity ...
For decades, lipid droplets have been considered as the main cellular organelles involved in the fat...
Among all neoplasms, melanoma is characterized by a very high percentage of cancer stem cells (CSCs)...
Cancer cells have been known to have reprogrammed metabolism since 1920s, when Otto Warburg observed...
Lipid Droplets (LDs) are emerging as crucial players in colon cancer development and maintenance. Th...
International audienceFor many years, scientists have been looking for specific biomarkers associate...
Label-free live single-cell Raman spectroscopy was used to obtain a chemical fingerprint of colorect...
The development of a colorectal adenoma (CA) into carcinoma (CRC) is a long and stealthy process. Th...
Colorectal cancer (CRC) is the fourth leading cause of cancer death in the world. Despite the screen...
Background Lipid-rich tumours have been associated with increased cancer metastasis and aggressive c...
Cancer stem cells (CSCs) are rare types of cells responsible for tumor development, relapse, and met...
Colon cancer constitutes 33% of all cancer cases in humans and the majority of patients with metasta...